Of the seven breast cancer cell lines examined in this study, BT474 and SKBr3 had the highest level of HER2 expression determined by flow cytometry (MFI values of 540.81 and 467.53, respectively), and were the most sensitive to treatment with HER-family inhibitors as single agents. Here, ERBB2 is linked to breast carcinoma.